Bill Gates’ Newest Mission: Curing Alzheimer’s

Alzheimer’s disease is the most common form of dementia and the sixth leading cause of death in the United States. To help the fight, Bill Gates is donating $50 million of his own money to the Dementia Discovery fund, a private-public research partnership focused on...

Senators Back Push For Stepped Up Tracking of Medical Devices

Two U.S. senators are pushing for change in the medical device industry. They are urging the agency that controls Medicare to support putting the full serial numbers for medical devices into insurance claims forms to better track how poorly performing devices affect...

Bayer Pays $400M Upfront to Buy into Loxo Cancer Drugs

Bayer, a life science company with focus in health care and agriculture has paid $400 million and committed to over $1 billion to buy into Loxo Oncology’s tropomyosin receptor kinase (TPK) inhibitor franchise. Loxo’s drug, has had a 75% success rate in its midphase...

Amazon Reportedly Considering PBM Partnership

In a recent Goldman Sachs report, technology giant and retail superpower, Amazon, is detailed as seeking a PBM partner. This would gain Amazon access to the pharmaceutical industry and make it easier for the supplier to take the place of many well-known distributors....

Novo Nordisk Sales Rise Despite Drug Price Concerns

Novo Nordisk has reported sales increases over the first half of 2017, despite drug pricing concerns. Sales of specific Novo Nordisk pharmaceuticals rose into the triple digit percentile, encouraging the company to re-analyze its 2017 profit margin figures. The...